APOTHECARY CONSULTING LIMITED

Company number 13129442 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

APOTHECARY CONSULTING LIMITED - Analysis Report

Company Number: 13129442

Analysis Date: 2025-07-20 15:56 UTC

Financial Health Assessment Report: Apothecary Consulting Limited


1. Financial Health Score: B

Explanation:
Apothecary Consulting Limited demonstrates solid growth and improving financial stability since its incorporation in 2021. The company shows healthy working capital, increasing net assets, and positive retained earnings, which reflect sound financial management. However, the relatively low cash balance compared to debtors and the absence of tangible fixed assets at the latest year-end suggest some liquidity caution and limited asset backing. Overall, the company’s financial health is good but with room to bolster liquidity and diversify assets.


2. Key Vital Signs

Metric 2025 (£) Interpretation
Current Assets 8,391 Adequate short-term resources, primarily debtors; showing business activity and sales on credit.
Cash at Bank 792 Low cash reserves indicate limited immediate liquidity; potential "cash flow tightness".
Debtors 7,599 High level of receivables; good sign of sales but raises risk if collections slow.
Current Liabilities 1,110 Manageable short-term obligations, well covered by current assets.
Net Current Assets 7,281 Strong positive working capital indicating good short-term financial health and operational liquidity.
Net Assets 7,281 Positive net worth, reflecting accumulated profits and retained earnings.
Shareholders’ Funds 7,281 Equity backing of the business has increased, a healthy sign of financial resilience.
Fixed Assets 0 No tangible fixed assets currently held; minimal capital investment in long-term resources.
Profit & Loss Reserve 7,122 Healthy retained earnings indicative of profitability since inception.

3. Diagnosis: Understanding the Financial Symptoms

  • Growth and Profitability: The company has steadily increased net assets from £159 in 2021 to £7,281 in 2025, driven by accumulated profits (£7,122 in reserves), which is a positive sign of profitability and successful operations in the health consulting sector.

  • Working Capital & Liquidity: There is a strong working capital position (£7,281), showing the business can cover its short-term debts comfortably. However, the low cash balance (£792) relative to high debtors (£7,599) suggests potential liquidity constraints. This "healthy cash flow" symptom is somewhat masked by reliance on debtor collections. The company might experience strain if customers delay payments.

  • Asset Base: The company holds no fixed assets at the year end 2025, having fully depreciated previous computer equipment. This is not unusual for a consulting business but points to a "lean" business model with minimal capital expenditure.

  • Capital Structure: Very low share capital (£1) but equity is built through retained earnings, indicating funding primarily from internal profits rather than external investment. The sole director and 100% shareholder maintains full control, which simplifies decision-making but may limit access to external capital.

  • Company Size and Compliance: Classified as a micro/small company with unaudited abridged accounts, filing is up to date without overdue filings or audit requirements, indicating compliance health.


4. Recommendations: Prescriptions for Financial Wellness

  • Improve Cash Reserves: To alleviate liquidity risk, focus on accelerating debtor collections and consider maintaining a higher cash buffer. This will reduce vulnerability to payment delays and unexpected expenses.

  • Debtor Management: Implement or strengthen credit control procedures to reduce the debtor days and improve cash inflow predictability. This could include timely invoicing, follow-ups, and possibly incentives for early payments.

  • Consider Asset Investment: Evaluate the need for reinvestment in fixed assets or technology that could enhance operational efficiency or service delivery, balancing cost against benefit to avoid overcapitalization.

  • Financial Planning: Develop a cash flow forecast and budget to anticipate and manage cash needs proactively. Scenario planning for slower debtor payments can prepare the business for potential stress.

  • Explore Funding Options: While internal funding suffices now, consider external financing options or partnerships if growth requires capital expansion, ensuring a balanced capital structure.

  • Maintain Compliance Vigilance: Continue to meet filing deadlines and statutory requirements to avoid penalties and maintain good corporate standing.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.